KB
Khoso Baluch

Khoso Baluch insider trades: Processa Pharmaceuticals (PCSA) stock buys and sales

Processa Pharmaceuticals Last trade Mar 31, 2026 32 Form 4 filings
$0
Sold, last 12 months
0 sales
$6K
Bought, last 12 months
1 buy
11
Open-market trades
since 2016
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Khoso reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 31, 2026PCSA↑ Buy$6K
Dec 2, 2024LGVN↓ Sell$3K
Dec 29, 2023LGVN↑ Buy$14K
Aug 13, 2020CRMD↑ Buy$20K
Mar 18, 2020CRMD↑ Buy$9K
Mar 26, 2019CRMD↑ Buy$19K
Nov 27, 2018CRMD↑ Buy$30K
Dec 12, 2017CRMD↑ Buy$50K
Aug 18, 2017CRMD↑ Buy$15K
May 17, 2017CRMD↑ Buy$36K
Dec 9, 2016CRMD↑ Buy$18K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PCSA insiders

Open-market trades in the last 12 months

About Khoso Baluch's insider trades

Khoso Baluch is an insider at Processa Pharmaceuticals (PCSA). Since Dec 9, 2016, Khoso has reported 10 open-market purchases worth $217K and 1 sale worth $3K on SEC Form 4. In the last 12 months: 1 buy ($6K).

Their filings also include grants and awards (18 filings), option exercises (2 filings), other transactions (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.